RxDoctor Payments Data

Jennifer Elliott, MD

Pain Medicine · Kansas City, MONPI 1265400980

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Novo Nordisk at 34.6% of the total. Reporting peaked in 2019 at $400 and has fallen 96.1% since, to $16 in 2025. That places this record below the midpoint for pain medicine clinicians in MO, where the typical reported total is $2,454.

$755in general payments, 2019–2025

Across 14 payments — averaging $53.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$261
  • Medtronic$146
  • Conmed Corporation$123
  • Abbott$90
  • AbbVie$35
  • Boston Scientific$34
  • plus $66 from 3 others
$14,046in research payments, 2019–2025

Across 5 payments — averaging $2809.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Globus Medical$12K
  • Nevro Corp.$2K

What the payments were for

  • Food & beverage$755100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk3$261
Medtronic1$146
Conmed Corporation1$123
Abbott1$90
AbbVie(2 entities)2$35
Boston Scientific2$34
GRT US Holding, Inc.2$34
Nevro Corp.1$17
GSK1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$755 in reported general payments places this provider in the 30th percentile of 124 pain medicine providers in Missouri.

See all pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$54,688
Medicare patients
206
Services billed
693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl11$11,392
Fentanyl85$7,216
Xtampza ErOxycodone Myristate16$6,875
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen157$4,187
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen116$4,099
Gabapentin154$3,979
Oxycodone Hcl106$2,189
Morphine Sulfate ErMorphine Sulfate87$1,557
Hydromorphone Hcl33$1,101
Morphine Sulfate39$839
Lidocaine14$605
Pregabalin32$599
Methadone Hcl11$595
Cyclobenzaprine Hcl41$336
Tramadol Hcl47$311

Paid to pharmacies, not to this prescriber.

Other pain medicine in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →